Anti-Parkinson's disease refers to the therapeutic strategies, medications, and interventions aimed at managing the symptoms and progression of Parkinson's disease (PD). PD is a progressive neurodegenerative disorder primarily affecting dopamine-producing neurons in the substantia nigra. Treatments focus on alleviating motor symptoms like tremor, rigidity, bradykinesia, and postural instability, and addressing non-motor symptoms to improve quality of life.